China's Covid-19 vaccine Convidecia receives emergency approval from WHO
In Taiwan, people line up to receive a vaccine dose, April 28, 2022. Illustrative image.
REUTERS - I-HWA CHENG
Text by: RFI Follow
2 mins
The World Health Organization (WHO) announced, Thursday, May 19, the emergency registration of the anti-Covid-19 vaccine Convidecia from Chinese laboratories CanSino Biologics, at a time when Beijing is fighting against a resurgence of the pandemic.
This vaccine is based on a modified human adenovirus, it is administered in a single dose and the WHO recommends it for all age groups from 18 years old, specifies a press release from the WHO, reports AFP.
Advertisement
Read more
The World Health Organization (WHO) announced on Thursday May 19 the emergency registration of the anti-Covid vaccine Convidecia from Chinese laboratories CanSino Biologics, at a time when Beijing is fighting against a resurgence of the pandemic.
This vaccine is based on a modified human adenovirus, it is administered in a single dose and the WHO recommends it for all age groups from 18 years old, specifies a press release from the WHO.
Ninth Covid-19 vaccine
The vaccine is 64% effective for the symptomatic form of Covid-19 and 92% against severe forms.
It is the ninth anti-Covid vaccine or a variation of a vaccine to receive this precious sesame from the WHO, which is a seal of quality, efficacy and safety.
An important indication for the health authorities of certain countries which do not have the means to carry out a serious evaluation themselves.
This label also allows the international Covax system to use it if necessary for vaccination, particularly in poor countries.
China has had to deal with an
unprecedented
resurgence of the pandemic in the country in
recent months ,
where the first cases of Covid-19 were detected at the end of 2019.
Always “zero Covid-19”
The Omicron variant and its sub-variants are so contagious that they manage to circumvent the very strict sanitary measures imposed by the Chinese authorities.
However, under the leadership of President Xi Jinping, the country continues to apply its “zero Covid” strategy, not hesitating to confine giant agglomerations like Shanghai for example for long weeks.
Living conditions so draconian that
the populations begin to rebel.
The WHO for its part considers that in the face of Omicron
the policy of zero Covid "
is not sustainable
".
(
with AFP
)
Newsletter
Receive all the international news directly in your mailbox
I subscribe
Follow all the international news by downloading the RFI application
google-play-badge_FR
China
Vaccines
Coronavirus
WHO